Cargando…

ATM-Deficient Cancers Provide New Opportunities for Precision Oncology

Poly-ADP ribose polymerase (PARP) inhibitors are currently used in the treatment of several cancers carrying mutations in the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2, with many more potential applications under study and in clinical trials. Here, we discuss the potential for e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jette, Nicholas R., Kumar, Mehul, Radhamani, Suraj, Arthur, Greydon, Goutam, Siddhartha, Yip, Steven, Kolinsky, Michael, Williams, Gareth J., Bose, Pinaki, Lees-Miller, Susan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140103/ https://www.ncbi.nlm.nih.gov/pubmed/32183301 http://dx.doi.org/10.3390/cancers12030687

Ejemplares similares

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
por: Jette, Nicholas R., et al.
Publicado: (2019)

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
por: Jette, Nicholas R., et al.
Publicado: (2020)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

ATM for service providers /
por: Adams, John
Publicado: (1997)

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
por: Liu, Zhenyu, et al.
Publicado: (2019)

Challenges, opportunities, and innovative statistical designs for precision oncology trials
por: Yin, Jun, et al.
Publicado: (2022)

Shifting Gears in Precision Oncology—Challenges and Opportunities of Integrative Data Analysis
por: Noh, Ka-Won, et al.
Publicado: (2021)

Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology
por: Hull, Rodney, et al.
Publicado: (2022)

Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
por: Wang, Yifan, et al.
Publicado: (2020)

OTHR-20. Precision neuro-oncology in the real world. Opportunity and challenges from a UK Oncology Centre
por: Apps, John, et al.
Publicado: (2022)

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis
por: Spector-Bagdady, Kayte, et al.
Publicado: (2022)

Nocodazole-Induced Expression and Phosphorylation of Anillin and Other Mitotic Proteins Are Decreased in DNA-Dependent Protein Kinase Catalytic Subunit-Deficient Cells and Rescued by Inhibition of the Anaphase-Promoting Complex/Cyclosome with proTAME but Not Apcin
por: Douglas, Pauline, et al.
Publicado: (2020)

Novel targets for ATM-deficient malignancies
por: Winkler, Johannes, et al.
Publicado: (2014)

PDGF gene expression and p53 alterations contribute to the biology of diffuse astrocytic gliomas
por: Kumar, Mehul, et al.
Publicado: (2023)

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Bioinformatics for precision oncology
por: Singer, Jochen, et al.
Publicado: (2017)

The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023)

Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs
por: Fiore, LD, et al.
Publicado: (2017)

An Emerging Role for Radiation Oncology in Precision Oncology
por: Goyal, Sharad, et al.
Publicado: (2016)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

Reseaux ATM
por: Boisseau, Marc, et al.
Publicado: (1994)

ATM in senescence
por: Aird, Katherine M., et al.
Publicado: (2015)

Diversity of ATM gene variants: a population-based genome data analysis for precision medicine
por: Fukunaga, Hisanori, et al.
Publicado: (2019)

Precision Detection Technology: Equipping Precision Oncology with Wings
por: Bai, Rilan, et al.
Publicado: (2020)

ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors
por: Ueno, Sayaka, et al.
Publicado: (2022)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

Future paradigms for precision oncology
por: Klement, Giannoula Lakka, et al.
Publicado: (2016)

Precision medicine in pediatric oncology
por: Forrest, Suzanne J., et al.
Publicado: (2018)

Precision medicine in pediatric oncology
por: Burdach, Stefan E. G., et al.
Publicado: (2018)

Editorial: Precision Medicine in Oncology
por: Re, Angela, et al.
Publicado: (2018)

Systems proteogenomics for precision oncology
por: Klauschen, Frederick
Publicado: (2019)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Precision Oncology—The Quest for Evidence
por: Soldatos, Theodoros G., et al.
Publicado: (2019)

Precision oncology in urothelial cancer
por: Liow, Elizabeth, et al.
Publicado: (2020)

Reinforcement Learning for Precision Oncology
por: Eckardt, Jan-Niklas, et al.
Publicado: (2021)

Global Implementation of Precision Oncology
por: Yam, Clinton, et al.
Publicado: (2021)

Quo vadis precision oncology?
por: Heinrich, Kathrin, et al.
Publicado: (2023)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u2ahf8j1l4lie6j86n14m9ncl5